Talley Talley

Dr. Talley Talley


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
TGTyler Green
Tyler Green
TTTalley Talley
Talley Talley
BBBradley Charles Bundy
Bradley Charles Bundy
Cell-free biosensors harness the selectivity of cellular machinery without living cells’ constraints, offering advantages in environmental monitoring, medical diagnostics, and biotechnological applications. This review examines recent advances in cell-free biosensor development, highlighting their ability to detect diverse analytes including heavy metals, organic pollutants, pathogens, and clinical biomarkers with high sensitivity and specificity. We analyze technological innovations in cell-free protein synthesis optimization, preservation strategies, and field deployment methods that have enhanced sensitivity, and practical applicability. The integration of synthetic biology approaches has enabled complex signal processing, multiplexed detection, and novel sensor designs including riboswitches, split reporter systems, and metabolic sensing modules. Emerging materials such as supported lipid bilayers, hydrogels, and artificial cells are expanding biosensor capabilities through microcompartmentalization and electronic integration. Despite significant progress, challenges remain in standardization, sample interference mitigation, and cost reduction. Future opportunities include smartphone integration, enhanced preservation methods, and hybrid sensing platforms. Cell-free biosensors hold particular promise for point-of-care diagnostics in resource-limited settings, environmental monitoring applications, and food safety testing, representing essential tools for addressing global challenges in healthcare, environmental protection, and biosecurity.

1 July 2025 in SynBio
Verified
Journal Article
Open access
PDF file
DCDallin M Chipman
Dallin M Chipman
AWAnna Claire Woolley
Anna Claire Woolley
DCDavu Chau
Davu Chau
WLWilliam A Lance
William A Lance
TTTalley Talley
Talley Talley
BBBradley Charles Bundy
Bradley Charles Bundy
Cell-free protein synthesis (CFPS) has transformed protein production capabilities by eliminating cellular constraints, enabling the rapid expression of difficult-to-produce proteins in an open, customizable environment. As CFPS applications expand from fundamental research to industrial production, therapeutic manufacturing, and point-of-care diagnostics, the diverse array of reactor formats has become increasingly important yet challenging to navigate. This review examines the evolution and characteristics of thirteen major CFPS reactor formats, from traditional batch systems to advanced platforms. The historical development of CFPS reactors from the 1960s to present day is presented. Additionally, for each format, operational principles, advantages, limitations, and notable applications are evaluated. The review concludes with a comparative assessment of reactor performance across critical parameters, including productivity, scalability, technical complexity, environmental stability, and application suitability. To our knowledge this structured analysis is the first to focus predominantly on the various reactor formats of cell-free systems and to provide a guide to assist researchers in choosing the reactor type that best fits their specific applications.

12 May 2024 in Sensors
Verified
Journal Article
Open access
PDF file
TFTyler Free
Tyler Free
TTTalley Talley
Talley Talley
CHChad D Hyer
Chad D Hyer
CMCatherine J. Miller
Catherine J. Miller
JGJoel S. Griffitts
Joel S. Griffitts
BBBradley Charles Bundy
Bradley Charles Bundy
Specialized cancer treatments have the potential to exploit glutamine dependence to increase patient survival rates. Glutamine diagnostics capable of tracking a patient’s response to treatment would enable a personalized treatment dosage to optimize the tradeoff between treatment success and dangerous side effects. Current clinical glutamine testing requires sophisticated and expensive lab-based tests, which are not broadly available on a frequent, individualized basis. To address the need for a low-cost, portable glutamine diagnostic, this work engineers a cell-free glutamine biosensor to overcome assay background and signal-to-noise limitations evident in previously reported studies. The findings from this work culminate in the development of a shelf-stable, paper-based, colorimetric glutamine test with a high signal strength and a high signal-to-background ratio for dramatically improved signal resolution. While the engineered glutamine test is important progress towards improving the management of cancer and other health conditions, this work also expands the assay development field of the promising cell-free biosensing platform, which can facilitate the low-cost detection of a broad variety of target molecules with high clinical value.

5 February 2025 in SynBio
Verified
Journal Article
Open access
PDF file
SYSeung Ook Yang
Seung Ook Yang
TTTalley Talley
Talley Talley
GNGregory Nielsen
Gregory Nielsen
KWKristen M. Wilding
Kristen M. Wilding
BBBradley Charles Bundy
Bradley Charles Bundy
Enzymes play an essential role in many different industries; however, their operating conditions are limited due to the loss of enzyme activity in the presence of proteases and at temperatures significantly above physiological conditions. One way to improve the stability of these enzymes against high temperatures and proteases is to encapsulate them in protective shells or virus-like particles. This work presents a streamlined, three-step, cell-free protein synthesis (CFPS) procedure that enables rapid in vitro enzyme production, targeted encapsulation in protective virus-like particles (VLPs), and facile purification using a 6× His-tag fused to the VLP coat protein. This process is performed in under 12 h and overcomes several limitations of enzyme encapsulation, such as the control of packing density, speed, and complexity of the process. Here, we encapsulate the enzyme Candida antarctica lipase B in the VLP from the bacteriophage Qβ, while in the presence of a linking RNA aptamer. The encapsulated enzymes largely retained their activity in comparison to the free enzymes. Additionally, when subjected to 90 °C temperatures or 5 h incubation with proteases, the encapsulated enzymes maintained their activity, whereas the free enzymes lost their activity. In this work, we also demonstrate control over packing density by achieving packing densities of 4.7 and 6.5 enzymes per VLP based off the concentration of enzyme added to the encapsulation step.

5 June 2025 in Chemosensors
Verified
Journal Article
Open access
PDF file
TTTalley Talley
Talley Talley
TFTyler J. Free
Tyler J. Free
TGTyler Green
Tyler Green
DCDallin M Chipman
Dallin M Chipman
BBBradley Charles Bundy
Bradley Charles Bundy
Glutamine is an essential biomolecule that plays a pivotal role in many diseases, such as cancer, where it can serve as fuel for rapid proliferation. Treatments for these diseases can be monitored and optimized through the detection of glutamine, though standard glutamine detection procedures are costly and require complex instrumentation. Cell-free protein synthesis (CFPS) has recently enabled a paper-based, colorimetric glutamine sensor that carries the potential to increase test accessibility while dramatically reducing consumer cost to enable at-home, rapid treatment monitoring. Test sensitivity remained limited by residual assay background, thus motivating this work where CFPS reactions traditionally formulated with glutamate salts were compared to systems using alternative salts, including aspartate, acetate, citrate, and sulfate, to reduce the background generation of glutamine. This led to the discovery of a novel aspartate-based CFPS system that boasts a high signal strength and indetectable background noise over 225 min. Acetate-, citrate-, and sulfate-based systems also yielded zero background glutamine detection but at a lower signal response compared to the aspartate-based system. These findings mark crucial advancements in producing a cost-effective, simple glutamine monitor while simultaneously showcasing the adaptability of CFPS’s open reaction environment for solving complex challenges in next-generation biosensor development.

29 August 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
TOTochukwu P. Okonkwo
Tochukwu P. Okonkwo
RGRajendra P. Gautam
Rajendra P. Gautam
JLJacob B. Limburg
Jacob B. Limburg
BFBreckin L. Forstrom
Breckin L. Forstrom
BHBowen J. Houser
Bowen J. Houser
RHRoger G. Harrison
Roger G. Harrison
Bacterial infections continue to drive the need for more effective and rapid methods for bacterial analysis. To address this, magnetic nanoparticles (MNPs) have emerged as promising tools, especially when their surfaces are modified with bacteria binders. The bis-zinc–dipicolylamine (Zn–DPA) complex is known for its broad affinity to bacteria. We have synthesized MNPs via a thermal decomposition method, encapsulated them in silica, modified their surface with Zn–DPA, and tested their ability to remove bacteria. The MNPs retain their superparamagnetic properties and crystallite structure after being encapsulated. The MNPs coated with silica and Zn–DPA effectively bind and remove both Gram-positive and Gram-negative bacteria from bacterial suspensions in both PBS buffer and red blood cell suspension. The capture efficiency (CE) of bacteria is high, >0.95 for both concentrated (1 × 108 CFU) and dilute (1 × 103 CFU) suspensions of Gram-positive and Gram-negative bacteria in PBS. The bacterial capture efficiency in red blood cell suspension with 50% hematocrit ranges is high (CE > 0.95) for both concentrated and dilute suspensions of S. aureus but lower for concentrated (CE = 0.30) and dilute (CE = 0.15) suspensions of E. coli. The Zn–DPA coated MNPs have promising binding efficiencies for a broad-spectrum of bacteria within a short period of time, potentially leading to applications in diagnostic devices for both medical and industrial uses.